The Effect of Composite Composition Ratio on the Physicochemical Characteristics of Bovine Hydroxyapatite-Chitosan-Ciprofloxacin Implant

Effect of Composite Composition on BHA-Chit-Cipro Implant

Authors

  • Karina Citra Rani
  • Teguh Imanto
  • Riesta Primaharinastiti
  • Dewi Melani Hariyadi
  • Esti Hendradi

Keywords:

Composite, Bovine hydroxyapatite, Chitosan, Ciprofloxacin, Bone implant

Abstract

This study aimed to develop bone implant as either deliver ciprofloxacin to the bone or regenerate bone defects. The effect of the composite composition ratio (Bovine Hydroxyapatite-Chitosan) on the physicochemical characteristics of Bovine Hydroxyapatite Chitosan-ciprofloxacin implant were evaluated in this study. Ciprofloxacin implants were prepared using four different compositions of composite (Bovine Hydroxyapatite-Chitosan) 20:80; 30:70; 40:60; and 70:30. The amount of ciprofloxacin in each implant was 10 %. The powder mixture was then pressed into pellets. The implants were evaluated by various parameters such as porosity, density, water absorption capacity, swelling ratio, disintegration test, compression force, drug assay, and in vitro drug release. Characterization of the implants was conducted using Fourier Transform Infrared (FT-IR), Scanning Electron Microscopy (SEM), and X-ray diffraction study. The results obtained from this work revealed that the composite composition ratio (Bovine Hydroxyapatite-Chitosan) influenced the differences in physical characteristics and the release of ciprofloxacin from Bovine Hydroxyapatite-Chitosan-ciprofloxacin implant. The increased in the Bovine Hydroxyapatite ratio in composite composition caused enhancement of physical characteristics (porosity, density, water absorption capacity, and compressive strength) of the implant. Meanwhile, increase in Bovine Hydroxyapatite ratio in implant caused lower release of ciprofloxacin. The best composite composition ratio to produce Bovine Hydroxyapatite-Chitosan-ciprofloxacin implant with desired physical characteristics and ciprofloxacin release was Bovine Hydroxyapatite-Chitosan (70:30).

References

Zo, S.M., D. Singh, A. Kumar, Y.W. Cho, T. Oh & S. Han. Chitosan-hydroxyapatite microporous matrix for bone tissue engineering. Current Science (Bangalore) 103: 1438–1445 (2012).

Jun, S., E. Lee, T. Jang, H. Kim, J. Jang & Y. Koh. Bone morphogenic protein-2 (BMP-2) loaded hybrid coating on porous hydroxyapatite scaffolds for bone tissue engineering Journal of Materials Science: Materials in Medicine 24: 773–782 (2013).

Sierra, D., J. Martins & C.P. Ossa-Orozco. Chitosan/hydroxyapatite scaffolds for tissue engineering manufacturing method effect comparison. Revista Facultad de Ingeniería Universidad de Antioquia 75: 24–35 (2015).

Elkayar, A., Y. Elshazly & M. Assad. Properties of hydroxyapatite from bovine teeth. Bone and Tissue Regener Insights 2: 31–36 (2009).

Ramachandra, R. & T. Kannan. Synthesis and sintering of hydroxyapatite-zirconia composites. Materials Science and Engineering: C 20:187–193 (2002).

Mezahi, F.Z., H. Oudadesse, A. Harabi, Y. Gal & G. Cathelineau. Sintering effects on physicochemical properties of bioactivity of natural and synthetic hydroxyapatite. Journal of the Australasian Ceramic Society 47: 23–27 (2011).

Mourino, V. & A.R. Boccaccini. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. Journal of the Royal Society Interface. 7: 209–227 (2010).

Habraken, W., J. Wolke & J. Jansen. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Advanced Drug Delivery Reviews 59: 234–248 (2007).

Kong, L., Y. Gao, W. Cao, Y. Gong, N. Zhao & X. Zhang. Preparation and characterization of nanohydroxyapatite chitosan composite scaffolds. Journal of Biomedical Materials Research Part A 75: 275–282 (2005).

Kong, L., Y. Gao, G. Lu, Y. Gong, N. Zhao & X. Zhang. A study on the bioactivity of chitosan/nanohydroxyapatite composite scaffolds for bone tissue engineering. European Polymer Journal. 42(12): 3171–3179 (2006).

Koonawot, R., S. Thiamsem, S. Punyanitya, A. Raksujarit & S. Laosatirawong. Structure and mechanical properties of rice starch and bovine bone powder composite films. Chiang Mai Medical Journal 49: 139–144 (2010).

Mi, F., Y. Tan, H. Liang & H. Sung. In vivo biocompatibility and degradability of a novel injectable chitosan-based implant. Biomaterials 23: 181–191 (2002).

Jin, H., D. Kim, T. Kim, K. Shin, J. Jung, H. Park & S. Yoon. In vivo evaluation of porous hydroxyapatite/chitosan-alginate composite scaffolds for bone tissue engineering. International Journal of Biological Macromolecules 51: 1079–1085 (2012).

Hillig, W.B., Y. Choi, S. Murtha, N. Natravali & P. Ajayan. An open-pored gelatin/hydroxyapatite composite as a potential bone substitute. Journal of Materials Science: Materials in Medicine. 19:11–17 (2008).

Teng, S.H., E.J. Lee, B.H. Yoon, D.S. Shin, H.E. Kim & J.S. Oh. Chitosan/nanohydroxyapatite composite membranes via dynamic filtration for guided bone regeneration. J Biomed Mater Res Part B. 88: 569–579 (2008).

Teng, S.H., E.J. Lee, P. Wang, S.H. Jun, C.M. Han & H.E. Kim. Functionally gradient chitosan/hydroxyapatite composite scaffolds for controlled drug release. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 10: 275–282 (2009).

Liu, T., S. Chen, J. Li & D. Liu. Study on drug release behavior of CDHA/chitosan nanocomposites – the effect of CDHA nanoparticles. Journal of Controlled Release 112: 88–95 (2006).

Danilchenko, S.N., O.V. Kalinkevich, M.V. Pogorelov, A.N. Kalinkevich, A.M. Sklyar, T.G. Kalinichenko, et al. Chitosan-hydroxyapatite composite biomaterials made by a one-step coprecipitation method: preparation, characterization, and in vivo tests. Journal of Biological Physics and Chemistry 9: 119–126 (2009).

Campos, M., H. Rawls, L. Innocentini-Mei & N. Satsangi. in vitro gentamicin sustained and controlled release from chitosan cross-linked films. Journal of Materials Science: Materials in Medicine 20: 537–542 (2009).

Lei, L., L. Li & L. Zang. Structure and performance of nano-hydroxyapatite filled biodegradable poly(1,2-propanediol-sebacate)-citrate) elastomer. Polymer Degradation and Stability 94: 1494–1502 (2009).

Budiatin, S., M. Zainuddin & J. Khotib. A biocompatible composite as gentamicin delivery system for osteomyelitis and bone regeneration. International Journal of Pharmacy and Pharmaceutical Sciences 6: 1–3 (2014).

Yang, B., X.Y. Li, S. Shi, X. Kong, G. Guo & M. Huang. Preparation and characterization of a novel chitosan scaffold. Carbohydrate Polymers 80(3): 860–865 (2010).

Koort, J.K., T.J. Mäkinen, E. Suokas, M. Veiranto, J. Jalava, P. Törmälä & H.T. Aro. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant. Acta Orthopaedica 79 (2): 295–301 (2008).

Pawar, A.Y. & D.V. Derle. Development of costeffective biodegradable implants of ciprofloxacin hydrochloride in the treatment of osteomyelitis. Asian Journal of Pharmaceutics 2: 19–37 (2012).

Stallmann, H.P., C. Faber, A.L. Bronckers, A.V.N. Amerogen & P.I.M.J. Wuisman. in vitro gentamicin release from commercially available calcium-phosphate bone substitute influence of carrier type on the duration of the release profile. BMC Musculoskeletal Disorders 7: 1–8(2006).

Thein-Han, W.W. & R.D.K. Misra. Biomimetic chitosan-nanohydroxyapatite composite scaffolds for bone tissue engineering. Acta Biomaterialia 5(4): 1182–1197 (2009).

Sun, T., T.H. Khan & N. Sultana. Fabrication and in vitro evaluation of nanosized hydroxyapatite/chitosan-based tissue engineering scaffolds Journal of Nanomaterial 1: 1–8 (2014).

Venkatesan, J. & S. Kim. Chitosan composites for a bone tissue engineering-An overview. Marine Drugs 8: 2252–2266 (2008).

Makinen, T.J. et al. in vitro and in vivo release of ciprofloxacin from osteoconductive bone defectfiller. Journal of Antimicrobial Chemotherapy. 56: 1063–1068 (2005).

Adikwu, E. & N. Brambaifa. Ciprofloxacin induced chondrotoxicity and tendinopathy. American Journal of Pharmacology and Toxicology. 3: 94–100 (2012).

Razali, K.R., Mohd. Nasir, N.F., Cheng E.M., Mamat N., Mazalan M., Wahab Y., Roslan M.M. The effect of gelatin and hydroxyapatite ratios on the scaffold’s porosity and mechanical properties. Proceeding IEEE Conference on Biomedical Engineering and Sciences : 256-59 (2014).

Maji, K., Dasgupta S., Kundu B., Bissoyi, A. Development of gelatin-chitosan-hydroxyapatite based bioactive bone scaffold with controlled pore size and mechanical strength. Journal of Biomaterials Science, Polymer Edition. 26 (16):1-20 (2015).

Downloads

Published

2019-12-04

How to Cite

Karina Citra Rani, Teguh Imanto, Riesta Primaharinastiti, Dewi Melani Hariyadi, & Esti Hendradi. (2019). The Effect of Composite Composition Ratio on the Physicochemical Characteristics of Bovine Hydroxyapatite-Chitosan-Ciprofloxacin Implant: Effect of Composite Composition on BHA-Chit-Cipro Implant. Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences, 56(4), 61–74. Retrieved from https://ppaspk.org/index.php/PPAS-B/article/view/933

Issue

Vol. 56 No. 4 (2019)

Section

Research Articles

License

Creative Commons Attribution (CC BY). Allows users to: copy the article and distribute; abstracts, create extracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: includes a link to the license; indicates if changes were made; gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); and does not represent the author(s) as endorsing the adaptation of the article or modify the article in such a way as to damage the authors' honor or reputation.